WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007086929) NANOPARTICLE FORMATION OF PHARMACEUTICAL INGREDIENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/086929    International Application No.:    PCT/US2006/027222
Publication Date: 02.08.2007 International Filing Date: 07.07.2006
IPC:
A61K 9/51 (2006.01), A61K 31/64 (2006.01), A61K 31/405 (2006.01), A61K 31/5415 (2006.01), A61K 31/704 (2006.01)
Applicants: HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. [US/US]; Hewlett-Packard Company, Intellectual Property Administration, 20555 S.h. 249, Houston, Texas 77070 (US) (For All Designated States Except US).
CHINEA-HERNANDEZ, Vanessa I. [US/US]; (PR) (For US Only).
KANE, Kevin Michael [US/US]; (PR) (For US Only).
FARR, Isaac [US/US]; (US) (For All Designated States Except US).
FIGUEROA, Iddys D [US/US]; (PR) (For US Only)
Inventors: CHINEA-HERNANDEZ, Vanessa I.; (PR).
KANE, Kevin Michael; (PR).
FIGUEROA, Iddys D; (PR)
Agent: COULMAN, Donald J.; Hewlett-Packard Company, Intellectual Property Administration, P.o. Box 272400 Mail Stop 35, Fort Collins, Colorado 80527-2400 (US)
Priority Data:
11/332,131 13.01.2006 US
Title (EN) NANOPARTICLE FORMATION OF PHARMACEUTICAL INGREDIENTS
(FR) FORMATION DE NANOPARTICULES D’INGREDIENTS PHARMACEUTIQUES
Abstract: front page image
(EN)A pharmaceutical ingredient is dissolved within a solvent (102/302). The solvent is evaporated until nanoparticles of the pharmaceutical ingredient are at least partially formed without employing a substrate for them (104/306). A portion of the solvent remains, within which the nanoparticles are located.
(FR)Selon la présente invention, un ingrédient pharmaceutique est dissout dans un solvant (102/302). Le solvant est évaporé jusqu'à ce que des nanoparticules de l'ingrédient pharmaceutique soient au moins partiellement formées sans utiliser de substrat pour celles-ci (104/306). Une partie du solvant est conservée, dans laquelle se trouvent les nanoparticules.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)